Cellectis (CLLS) Other Accumulated Expenses: 2014-2022
Historic Other Accumulated Expenses for Cellectis (CLLS) over the last 1 years, with Mar 2022 value amounting to $1.1 million.
- Cellectis' Other Accumulated Expenses fell 74.60% to $1.1 million in Q1 2022 from the same period last year, while for Mar 2022 it was $1.1 million, marking a year-over-year decrease of 74.60%. This contributed to the annual value of $6.1 million for FY2020, which is N/A change from last year.
- Latest data reveals that Cellectis reported Other Accumulated Expenses of $1.1 million as of Q1 2022, which was down 74.60% from $4.2 million recorded in Q1 2021.
- Cellectis' 5-year Other Accumulated Expenses high stood at $6.1 million for Q4 2020, and its period low was -$1,198 during Q1 2019.
- Moreover, its 3-year median value for Other Accumulated Expenses was $5.1 million (2020), whereas its average is $4.3 million.
- As far as peak fluctuations go, Cellectis' Other Accumulated Expenses skyrocketed by 495,926.38% in 2020, and later tumbled by 74.60% in 2022.
- Over the past 5 years, Cellectis' Other Accumulated Expenses (Quarterly) stood at $1.0 million in 2018, then slumped by 42.28% to -$1,198 in 2019, then spiked by 495,926.38% to $6.1 million in 2020, then declined by 29.14% to $4.2 million in 2021, then slumped by 74.60% to $1.1 million in 2022.
- Its Other Accumulated Expenses stands at $1.1 million for Q1 2022, versus $4.2 million for Q1 2021 and $6.1 million for Q4 2020.